This funding opportunity supports research proposals that conduct secondary analysis and integration of existing clinical, environmental, genomic, and molecular datasets to elucidate cancer risk and related outcomes. Applications should propose innovative methods or novel data combinations to address key scientific questions in cancer research. Clinical trials are not allowed under this initiative.
Eligible applicants include a wide range of organizations such as private and public institutions of higher education, nonprofits, for-profit organizations, tribal governments, small businesses, and various government entities including state, county, and special district governments.
